Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584–595 (2009). Takahashi, K. & Yamanaka, S. Induction of ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Dr. Christopher Navara has 15 years of experience in pluripotent stem cell research including both humans and non-human primates. To date he has derived or isolated over 50 cell lines from rhesus ...

These organoids provide scientists with better models for studying liver biology, and for developing treatments for various liver disorders.

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

In 1981 Martin Evans, Matthew Kaufman and Gail Martin isolated pluripotent embryonic stem cells from ... circulation or metabolism, influence tissue renewal. Nowadays, mini-organs, or 3D-organoids, ...

One reason why our livers excel at clearing waste from our blood system is that the organ functions according to three key ...

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

Lipids and membranes Starting from induced pluripotent stem cells (iPSCs) differentiated into human Schwann cells ... PMP22 duplication dysregulates lipid metabolism and disrupts the normal ...

The SKI Stem Cell Research Core stocks, characterizes, and distributes human pluripotent stem cell (hPSC) lines. We perform a variety of hPSC-related applications for the stem cell community at SKI ...